Along similar lines, IFNγ signaling can also boost the expression of non-classical MHC class Ia genes, such as HLA-G, -E and -F, which are known to endow cancer cells with ability to evade CTL and NK cell responses [67,85]. Here, HLA-G is linked to cancer.